Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Best Practice & Research. Clinical Rheumatology|September 19, 2006
B cell depletion therapy in rheumatic diseaseJ C W Edwards, G Cambridge, M J LeandroRheumatic Diseases Clinics of North America|June 3, 2004
B lymphocyte depletion therapy with rituximab in rheumatoid arthritisJ C W Edwards, M J Leandro, G CambridgeBiochemical Society Transactions|August 28, 2002
B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disordersJ C W Edwards, M J Leandro, G CambridgeAnnals of the Rheumatic Diseases|September 14, 2002
Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletionM J Leandro, J C W Edwards, G CambridgeRheumatology (Oxford, England)|December 26, 2006
Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrsC Popa, M J Leandro, G Cambridge, et al.Rheumatology (Oxford, England)|June 1, 2006
Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapyM J Leandro, N Cooper, G Cambridge, et al.Annals of the Rheumatic Diseases|October 2, 2007
B cell depletion therapy for patients with systemic lupus erythematosus results in a significant drop in anticardiolipin antibody titresY Ioannou, A Lambrianides, G Cambridge, et al.Annals of the Rheumatic Diseases|October 27, 2007
B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical responseG Cambridge, D A Isenberg, J C W Edwards, et al.Clinical and Experimental Immunology|August 12, 2017
B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsetsE Becerra, I De La Torre, M J Leandro, et al.Journal of Autoimmunity|December 25, 2013
The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatmentG Cambridge, H C Perry, L Nogueira, et al.Pageof 7